EMA Issues Q&A on Health-Based Exposure Limits and Prevention of Cross-Contamination

Drug Industry Daily
A A
The European Medicines Agency released Q&A guidance on prevention of cross-contamination and setting health-based exposure limits (HBELs) for risk identification during drug manufacturing in shared facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily